SHG
SINGHEALTH FPO [SHG]
Healthcare · ASX Small Cap
$0.2500 -5.7%
Updated 2026-03-02 · Scores refresh every scan
⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.
Appeared in 2 consecutive scans→ Score +9First seen: 2026-02-25
Score Breakdown
Technical37
Catalyst50
Sentiment50
Fundamental46
Momentum51
Risk Gate50
Active Signals
Bullish Signals
- Golden cross (bullish)
- OBV divergence: distribution detected
- Low cash runway (3 quarters) - dilution risk
- 4C filed 2026-01-26
- Very high P/S ratio (63.7x)
- Strong revenue growth (+42%)
- Small-cap ($20-100M)
- Capital raise activity (1 events)
- Strong revenue momentum (+42%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE2 (est. 2024-07-01)
Risk Signals
- Stochastic bearish crossover (from high)
- Negative 5-day momentum (-3.8%)
- Below 200-day MA (long-term downtrend)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Negative 12-1 momentum (-22%)
Recent Catalysts
NONE Change of Registered Office and Place of Business
NONE Appendix 4D Half Yearly Report and Accounts
NONE Exercise of Options and Cleansing Notice
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Recent ASX Announcements
| 2026-02-27 | Change of Registered Office and Place of Business |
| 2026-02-23 | Appendix 4D Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-01-26 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
| 2026-01-20 | Exercise of Options and Cleansing Notice |
| 2026-01-20 | Application for quotation of securities - SHG |
Key Metrics
$83.7M
Market Cap
492K
Avg Volume
1.2x
Vol Ratio
$0.18 — $0.42
52-Week Range
N/A
Short Interest
2 qtrs
Cash Runway
-90.1%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 68% |
| L | Leader vs Laggard | laggard | RS: -1 |
| I | Institutional Sponsorship | weak | Inst: 2% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #36 of 119 · Sector avg: 51
View all Healthcare signals →